UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
BlueLinx
BXC
$706M
| $492K | ﹤0.01% |
7,919
+1,395
| +21% | +$101K |
|
2302
Crescent Energy
CRGY
$3.82B
| $491K | ﹤0.01% |
36,461
-2,636
| -7% | -$38.6K |
|
|
LGF.A
2303
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $489K | ﹤0.01% |
65,788
-12,944
| -16% | -$124K |
|
2304
Liquidity Services
LQDT
$1.32B
| $486K | ﹤0.01% |
29,898
+4,040
| +16% | +$71.1K |
|
2305
CEVA Inc
CEVA
$1.08B
| $485K | ﹤0.01% |
18,490
-1,321
| -7% | -$42.4K |
|
|
NNDM
2306
Nano Dimension
NNDM
$343M
| $485K | ﹤0.01% |
202,911
-5,882
| -3% | -$18K |
|
2307
Enact Holdings
ACT
$6.73B
| $481K | ﹤0.01% |
21,704
+4,735
| +28% | +$114K |
|
|
ME
2308
DELISTED
23andMe Holding Co
ME
| $481K | ﹤0.01% |
8,407
+1,154
| +16% | +$75.5K |
|
2309
Definitive Healthcare
DH
$75.3M
| $480K | ﹤0.01% |
30,862
-2,409
| -7% | -$53K |
|
|
DM
2310
DELISTED
Desktop Metal, Inc.
DM
| $479K | ﹤0.01% |
18,492
-5,658
| -23% | -$158K |
|
2311
Codexis
CDXS
$158M
| $478K | ﹤0.01% |
78,940
+12,505
| +19% | +$101K |
|
2312
indie Semiconductor
INDI
$854M
| $477K | ﹤0.01% |
65,133
-3,230
| -5% | -$23.9K |
|
2313
Collegium Pharmaceutical
COLL
$956M
| $476K | ﹤0.01% |
29,717
+1,558
| +6% | +$27.5K |
|
|
DNMR
2314
DELISTED
Danimer Scientific, Inc.
DNMR
| $475K | ﹤0.01% |
4,025
+2,312
| +135% | +$412K |
|
2315
Stoneridge
SRI
$213M
| $474K | ﹤0.01% |
27,961
-2,725
| -9% | -$51.2K |
|
2316
PetMed Express
PETS
$42.3M
| $471K | ﹤0.01% |
24,146
+331
| +1% | +$7.03K |
|
2317
Vuzix
VUZI
$224M
| $471K | ﹤0.01% |
81,306
-13,510
| -14% | -$104K |
|
2318
Interface
TILE
$2.22B
| $469K | ﹤0.01% |
52,219
| – | – |
|
2319
Heron Therapeutics
HRTX
$92.9M
| $467K | ﹤0.01% |
110,752
| – | – |
|
2320
HealthStream
HSTM
$840M
| $467K | ﹤0.01% |
21,957
| – | – |
|
2321
Unisys
UIS
$217M
| $467K | ﹤0.01% |
61,812
-8,502
| -12% | -$90.8K |
|
|
HONE
2322
DELISTED
HarborOne Bancorp
HONE
| $465K | ﹤0.01% |
34,639
-2,701
| -7% | -$38.1K |
|
|
INFA
2323
DELISTED
Informatica
INFA
| $463K | ﹤0.01% |
23,057
-208
| -0.9% | -$4.49K |
|
|
NXDR
2324
Nextdoor Holdings
NXDR
$986M
| $461K | ﹤0.01% |
165,116
+42,730
| +35% | +$141K |
|
|
SFIX
2325
Stitch Fix
SFIX
$560M
| $459K | ﹤0.01% |
116,308
+14,549
| +14% | +$82.6K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.